Predictive factors of a worse response to radioactive Iodine-I131 treatment in hyperthyroidism: outcome analysis in 424 patients. A single centre experience
Monica Finessi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Désirèe Deandreis, Loredana Pagano(University of Turin), Giancarlo Castellano(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Alessandro Bisceglia(University of Turin), Ruth Rossetto Giaccherino(University of Turin), G Bisi, Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Ezio Ghigo(Diabetes Australia)
Cited by 15
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
|The Journal of Clinical Endocrinology & Metabolism|2019|363
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index
|European Journal of Endocrinology|2005|317